Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 08 04:00PM ET
1.39
Dollar change
-0.02
Percentage change
-1.42
%
Index- P/E- EPS (ttm)-1.61 Insider Own15.95% Shs Outstand22.05M Perf Week4.51%
Market Cap35.04M Forward P/E- EPS next Y-1.57 Insider Trans-15.56% Shs Float21.19M Perf Month8.59%
Income-31.75M PEG- EPS next Q-0.35 Inst Own6.81% Short Float9.08% Perf Quarter-35.35%
Sales0.00M P/S- EPS this Y21.82% Inst Trans-15.68% Short Ratio0.83 Perf Half Y-64.08%
Book/sh0.69 P/B2.01 EPS next Y-5.34% ROA-87.09% Short Interest1.92M Perf Year452.68%
Cash/sh1.23 P/C1.13 EPS next 5Y- ROE-289.26% 52W Range0.17 - 9.77 Perf YTD-68.41%
Dividend Est.- P/FCF- EPS past 5Y62.66% ROI-114.99% 52W High-85.77% Beta-1.81
Dividend TTM- Quick Ratio2.17 Sales past 5Y0.00% Gross Margin- 52W Low717.65% ATR (14)0.10
Dividend Ex-Date- Current Ratio2.17 EPS Y/Y TTM38.47% Oper. Margin0.00% RSI (14)50.89 Volatility6.89% 7.12%
Employees17 Debt/Eq1.20 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price22.67
Option/ShortYes / Yes LT Debt/Eq0.63 EPS Q/Q21.04% Payout- Rel Volume0.10 Prev Close1.41
Sales Surprise- EPS Surprise-4.17% Sales Q/Q- EarningsAug 08 AMC Avg Volume2.30M Price1.39
SMA201.61% SMA501.18% SMA200-52.21% Trades Volume234,647 Change-1.42%
Date Action Analyst Rating Change Price Target Change
Mar-14-24Initiated Scotiabank Sector Outperform $13
Feb-08-24Initiated Jefferies Buy $15
Sep-20-24 04:30PM
Sep-18-24 08:00AM
Sep-05-24 08:00AM
Aug-23-24 04:30PM
Aug-21-24 08:00AM
08:00AM Loading…
Aug-15-24 08:00AM
Aug-08-24 04:56PM
Jun-20-24 08:13AM
08:00AM
07:28AM
Jun-18-24 06:22PM
Jun-07-24 04:30AM
May-21-24 08:00AM
May-09-24 04:29PM
Apr-26-24 04:05PM
08:00AM Loading…
Apr-09-24 08:00AM
Apr-04-24 08:00AM
Mar-19-24 09:53PM
04:25PM
Mar-12-24 08:00AM
Mar-05-24 04:30PM
Feb-26-24 08:00AM
Feb-02-24 04:30PM
Jan-05-24 04:05PM
Dec-01-23 04:15PM
Nov-20-23 08:00AM
Nov-08-23 05:17PM
Oct-12-23 08:25AM
Oct-11-23 04:29PM
08:01AM
08:00AM Loading…
08:00AM
07:41AM
Oct-10-23 04:05PM
Sep-19-23 08:00AM
Sep-05-23 08:00AM
Aug-10-23 04:13PM
Jul-19-23 08:00AM
May-31-23 04:05PM
May-25-23 05:00PM
May-19-23 04:05PM
May-10-23 04:15PM
Apr-28-23 08:00AM
Apr-27-23 04:58PM
Apr-26-23 06:41PM
Apr-17-23 09:00AM
Mar-22-23 05:26PM
Mar-15-23 04:05PM
Mar-14-23 04:30PM
Nov-22-22 04:05PM
Nov-10-22 09:00AM
Nov-08-22 08:00AM
Nov-02-22 08:00AM
Oct-06-22 08:00AM
Sep-07-22 08:00AM
Aug-15-22 08:00AM
Jul-07-22 08:00AM
Jun-09-22 08:00AM
Jun-06-22 04:05PM
May-26-22 04:57PM
May-13-22 08:00AM
Apr-27-22 10:01AM
08:00AM
Apr-08-22 01:00PM
Mar-29-22 04:00PM
Mar-10-22 08:00AM
Mar-08-22 04:30PM
Feb-09-22 08:00AM
Nov-18-21 08:00AM
Nov-12-21 07:00AM
Nov-10-21 04:05PM
Nov-09-21 08:00AM
Nov-08-21 08:00AM
Oct-01-21 08:00AM
Sep-20-21 08:00AM
Sep-13-21 08:00AM
Sep-09-21 04:01PM
Aug-12-21 04:01PM
Aug-09-21 08:00AM
Jul-09-21 08:00AM
Jul-01-21 04:00PM
Tempest Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development and discovery of small molecule drugs for the treatment of cancer. The company was founded in 2011 and is headquartered in Brisbane, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Versant Venture Capital VI, L.OwnerAug 12 '24Proposed Sale1.10387,999426,993Aug 13 08:03 AM
Versant Venture Capital VI, L.10% OwnerAug 08 '24Sale1.35400,000540,040597,940Aug 12 08:33 PM
Versant Venture Capital VI, L.10% OwnerAug 12 '24Sale1.10387,999426,993209,941Aug 12 08:33 PM
Versant Venture Capital VI, L.10% OwnerAug 08 '24Proposed Sale18.03400,0007,210,532Aug 09 03:41 PM
Brady Stephen RPresident and CEOJul 03 '24Buy2.1135,00073,85046,376Jul 08 04:15 PM
Whiting SamuelChief Medical OfficerJul 02 '24Buy2.134,6729,9519,573Jul 03 07:35 PM
Trojanowski JustinCorporate ControllerJun 28 '24Buy2.167,50016,20022,168Jul 02 04:15 PM